13F-HR filed by Versant Venture Management, LLC
Versant Venture Management, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 12 holding rows worth $962,969,000.
- Accession
- 0000950123-21-002373
- Filer
- CIK 1560009
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 12 entries on the cover page, a total value of $962,969,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $962,968,000 with VALUE read as thousands by filing date, 13F file number 028-16849. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 3,040,462 | $465,525,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 2,298,217 | $200,611,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,292,339 | $91,033,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 5,003,892 | $54,242,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 3,842,578 | $44,343,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,465,384 | $30,333,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,030,616 | $28,652,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 777,727 | $20,065,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 4,450,638 | $17,536,000 | thousands by filing date | |
| APREA THERAPEUTICS INC | 03836J102 | COM | 1,426,328 | $7,018,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 543,753 | $3,121,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 101,855 | $489,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-002373 | this filing | 2021-02-16 | acceptance time not in the bulk data set |